GoodRx becomes pricing source for Pfizer and other drugmakers on TrumpRx
GoodRx (GDRX) announced that it has become a major integration partner for Pfizer (PFE) and other pharmaceutical companies,...
Tag: PFE
Pfizer – Roivant tie-up generates positive mid-stage data for lead asset
Priovant Therapeutics, a company established in 2021 as part of a transaction between Pfizer (PFE) and Roivant Sciences...
4 stocks to watch on Friday: PM, PFE, MSTR, HIMS
Stock index futures rose on Friday, a day after Wall Street’s sell-off, while investors digested Amazon’s earnings...
Pfizer wins FDA priority review for Hympavzi label expansion
Pfizer (PFE) announced on Friday that the U.S. Food and Drug Administration granted priority review for a marketing...
Large-cap stocks with lowest dividend growth grade
As we navigate through the unpredictable market conditions, below is a list of the bottom 10 large cap stocks with the...
Bristol-Myers posts Q4 beat as growth portfolio offsets legacy headwinds
Bristol-Myers Squibb (BMY) added ~2% in the premarket on Thursday after the New Jersey-based pharma giant reported...
Pfizer outlines $150B obesity market strategy as VESPER-3 data supports monthly GLP-1 approach
Earnings Call Insights: Pfizer Inc. (PFE) Q4 2025 CEO Albert Bourla stated, "2025 was a very good year for Pfizer. I'm very...
Pfizer slips as analysts react to underwhelming outlook, obesity drug data
Pfizer (PFE) fell ~5% on Tuesday as Wall Street analysts assessed mid-stage data the company posted for its obesity therapy...
4 stocks to watch on Tuesday: PFE, MRK, HPQ, PYPL
Stock index futures were higher on Tuesday as investors looked to build on recent gains. Here are the four stocks to watch...
Pfizer projects annual revenue decline amid $1.5B hit from patent cliffs
Pfizer (PFE) shares fell in the premarket on Friday after the company reaffirmed its full-year outlook, indicating a revenue...